NF-1score: A prediction score for internal neurofibromas in neurofibromatosis-1

Journal of Investigative Dermatology

Volumn 130, Issue 9, 2010, Pages 2173-2178

  Sbidian, Emilie ^a,b   Wolkenstein, Pierre ^a,b   Valeyrie Allanore, Laurence ^a,b   Rodriguez, Diana ^b,c,d,e   Hadj Rabia, Smail ^c,f,g   Ferkal, Salah ^b   Lacour, Jean Philippe ^h   Leonard, Jean Claude ⁱ   Taillandier, Luc ^j   Sportich, Stéphanie ^k   Berbis, Philippe ^k   Bastuji Garin, Sylvie ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Réseau NF Ile de France ^*  (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ Institut Calot Helio Marin   (France)

^j Service de Neurologie   (France)

^k HÔPITAL NORD   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CALIBRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMA; NEUROFIBROMATOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; VALIDATION STUDY;

ADULT; AGED; CAFE-AU-LAIT SPOTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MORBIDITY; NEUROFIBROMATOSIS 1; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SUBCUTANEOUS TISSUE; YOUNG ADULT;

EID: 77955694078     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.100     Document Type: Article

References (24)

1. Coste J, Wasserman D, Venot A (1996) Predicting mortality in adult burned patients: methodological aspects of the construction and validation of a composite ratio scale. J Clin Epidemiol 49:1125-1131
2. Doorn PF, Molenaar WM, Buter J et al. (1995) Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 21:78-82
3. Drouet A, Wolkenstein P, Lefaucheur JP et al. (2004) Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain 127:1993-2009
4. Evans DG, Baser ME, McGaughran J et al. (2002) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Med Genet 39:311-314
5. Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1728 patients. Am J Med Genet A 70:138-143
6. Hanley JA, McNeil BJ (1982) The meaning and the use of the area under a receiver operating characteristic (ROC) curve. Diagn Radiol 143:29-36
7. Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387
8. Hosmer DW, Lemeshow S (1989) Applied Logistic Regression. New York, NY: John Wiley and Sons Inc.
9. Kaufmann D, Müller R, Bartelt B et al. (2001) Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene. Am J Hum Genet 69:1395-1400
10. Khosrotehrani K, Bastuji-Garin S, Zeller J et al. (2003) Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. Arch Dermatol 139:187-191
11. Khosrotehrani K, Bastuji-Garin S, Riccardi VM et al. (2005) Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. Am J Med Genet A 132A:49-53
12. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
13. Mautner VF, Hartmann M, Kluwe L et al. (2006) MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology 48:160-165
14. Miller ME, Hui SL (1991) Validation techniques for logistic regression models. Stat Med 10:1213-1226
15. National Institutes of Health Consensus Development Conference. Conference statement (1988) Neurofibromatosis. Arch Neurol 45:575-578
16. Pinson S, Créange A, Barbarot S et al. (2001) Neurofibromatose 1: recommanda-tions pour la prise en charge. Ann Dermatol Venereol 128:567-575
17. Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis type 1: an analysis using US death certificates. Am J Hum Genet 68:1110-1118
18. Sabbagh A, Pasmant E, Laurendeau I et al. (2009) Unravelling the genetic basis of variable clinical expression in Neurofibromatosis type 1. Hum Mol Genet 18:2768-2778
19. Steyerberg EW, Borsboom GJ, van Houwelingen HC et al. (2004) Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med 23:2567-2586
20. Steyerberg EW, Eijkemans M, Harrell FE et al. (2000) Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19:1059-1079
21. Tonsgard JH, Kwak SM, Short MP et al. (1998) CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology 50:1755-1760
22. Tucker T, Wolkenstein P, Revuz J et al. (2005) Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 65:205-211
23. Valeyrie-Allanore L, Ismaili N, Bastuji-Garin S et al. (2005) Symptoms associated with malignancy of peripheral nerve sheath tumors: a retrospective study of 69 patients with neurofibromatosis. Br J Dermatol 153:79-82
24. Van Houwelingen JC, Le Cessie S (1990) Predictive value of statistical models. Stat Med 9:1303-1325